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Introduction
Human antibodies or immunoglobulins were originally defined as gamma () globulins because of their mobility to the gamma region of paper electrophoresis. Subsequently, isotypes were defined serologically and structurally by the unique amino acid sequences of their constant heavy chain regions encoding the chromosome 14q32.3 (5´, , 3, 1,, 1, 2, 4, , 2 3´). IgG was registered by 4 IgG subclasses (Table 1A ). The polymorphisms of IgG are studied by GM allotypes as genetic markers of the immunoglobulin constant heavy G chains (IGHG) (Fc) (GM) genes (Table 1B) , inherited in Mendelian fashion and allelic exclusion [1] [2] [3] . The distinguished alternative allotypes of 3-, 1and 2chain genes express allelic IgG subclasses IgG3*b, IgG3*g, IgG1*f, IgG1*a, IgG2*n and IgG2*-n (Table 1C) , which are unique entities with different structures and functions. Both IGHG gene mapping and quantities of allelic IgG subclasses are assessed by a sensitive competitive ELISA [4] [5] [6] , at individual and population levels. The genome-wide association studies (GWAS) and
HapMap catalogue do not include GM immunoglobulin genes in their genotyping platform [7] [8] [9] . By serological methods the IGHG genes are registered as alleles (allotypes), genes, haplotypes and diplotypes ( Table 1 -4) . The haplotypes are markers of B cells [10] (Table 3 ).
The new variants of allelic IgG3, IgG1 and IgG2 subclasses were investigated for structural and functional differences. Various infectious antigens and allergens affect particular IGHG genes, responding differently to viral and bacterial infections, in allergy, immunodeficiency, autoimmunity and malignancy and responding differently on active immunotherapy (vaccines) and passive immunotherapy (IVIG, recombinant monoclonals).
Individuals are mapped according to the IGHG gene map (Table 2 ) and the gene activity by allelic IgG subclass quantities in comparison to reference values of healthy Caucasian adults and children ( Fig. 1, 2 , Table 5 ) [9] . Different properties of IGHG genes suggest that the Darwinian selection over many generations have played a role in the maintenance of polymorphisms of IGHG genes, of which some are common others rare. In this review we summarize the current understanding of the influence of IGHG genes on human immunity. We discuss the results from dissecting the IGHG (Fc) (GM) gene complex, to present the individual IgG immunity. We highlight the role of restrictive IGHG genes defining the individual allelic IgG subclass molecules and individual B cells in various diseases and therapy 2. Dissection of the human immunoglobulin heavy constant G chain (IGHG) (Fc) (GM) gene complex from chromosome14q32.3 (5´, , 3, 1,, 1, 2, 4, , 2 3´) by GM allotypes
The immunoglobulin heavy constant G chain (IGHG) genes are found on chromosome14q32.3 (5´, , 3, 1, , 1, 2, 4, , 2 3´). The IgG3, IgG1 and IgG2 subclasses can be differentiated by the distinguished alternative GM allotypes of 3 chains:*b/5 and/or *g/21, of 1 chains :*f/3 and/or *a/1 and of 2 chains: *n/23 and/or *-n/-23 (Table 1B ) They have unique structures by minor amino acid differences (Table 6) , correlating with single-base substitutions in the genes. The 6 alternative IgG subclasses are new unique entities of IgG3: IgG3*b or IgG3*g; of IgG1: IgG1*f or IgG1*a; of IgG2: IgG2*n or IgG2*-n (Table 1C) . 9 homozygous or heterozygous IGHG (Fc) (GM) genes. 3 variants of each 3, 1 and 2, (Table 1D ) express the individual molecules of IgG3: IgG3*b/*b, IgG3*b/*g, IgG3*g/*g; of IgG1: IgG1*f/*f, IgG1*f/*a, IgG1*a/*a; and of IgG2: IgG2*n/*n, IgG2*n/*-n, IgG2*-n/*-n (Table 1E ). 4 haplotypes are fixed combinations of 3-, 1and 2alleles; IGHG*bfn, IGHG*bf-n, IGHG*gan and IGHG*ga-n (Table 3 ).They are found in homozygous and heterozygous forms, of parental origin, and constitute 10 individual diplotypes, six common and 4 rare ( Table 2, 4) . Homozygous alleles and haplotypes are highlighted as they express restricted qualities of IgG subclass molecules. They are often associated with the extreme disease phenotypes. A B cell variation is described from the expression of IGHG haplotypes [10] .
Mode of inheritance of alternative IGHG (Fc) (GM) genes
The IgG class is divided in 4 subclasses. All four IgG subclasses are simultaneously present in single individuals, but the expressions of 3, 1 and 2 chains are defined by the inherited alternative IGHG (GM) allotypes [1] [2] [3] [4] . The distinguished alternative IGHG(GM) allotypes (alleles) are expressed as homozygous or heterozygous IGHG genes constituting the IgG subclass gene. IGHG gene mapping and corresponding levels of serum allotypic (allelic) IgG subclasses were analysed with a new ELISA method [4] . The 6 allotypes(alleles) define 9 homozygous or heterozygous genotypes (Table 1D ). There is a strong linkage disequilibrium between 3 and 1 alleles as *bf and *ga. The 2 *n or 2*-n are added in known fixed combinations of allotypes, in 4 haplotypes [3] : IGHG*bfn, IGHG*bf-n, IGHG*gan and IGHG*ga-n ( Table 3 ).The 4 haplotypes define 10 individual IGHG diplotypes, in homozygous or heterozygous forms. Of the 10 diplotypes 6 are common, while 4 containing the IGHG*gan are very rare ( Table 4 ). The 2 *n allele is found nearly exclusively in the levels of a healthy Caucasian population were given and used as references when investigating different diseases ( Table 2, 5) . Thus the individual homozygous IGHG diplotypes contain restricted qualities of IgG, compared to the normal serum pool, which contains all 6 IgG variants: IgG3*b, IgG3*g, IgG1*f, IgG1*a, IgG2*n and IgG2*-n ( Fig. 1 ).
The Mendelian inheritance was confirmed in a study of 200 children and their parents.
IGHG haplotypes indirect markers of B cells
B *bfn or B1, B *bf-n or B2, B *ga-n or B4 and one rare B *gan or B3 subsets B cells are the only cells producing immunoglobulins and they could be mapped according to the 4 IGHG haplotypes found in the population. The expression of IGHG haplotypes are indirect markers of at least 4 inherited B cells variants, 3 common B *bfn or B1, B *bf-n or B2, B *ga-n or B4 and one rare B *gan or B3 (Table 3) 
The IGHG (Fc) (GM) gene map

Reference levels of allelic IgG subclasses
Immunological/serological methods A sensitive competitive ELISA (sensitivity1000ng/ml) was used to register IGHG genes as allotypes and quantify serum IgG1*f, IgG1*a, IgG2*n and IgG3*b allotypes [6] with the following monoclonal antibodies: anti IgG1*f clone 5F10, anti IgG1*a clone 5E7, anti IgG3*b1/u clone clone 12D9 (Janssen Biochimica, Beerse, Belgium) and anti IgG2*n clone SH21 (Sigma, St. Louis, MO, USA). Microtitre plates were coated with a predetermined concentration of purified myeloma proteins of the following IgG allotypes: IgG1*f, IgG1*a, IgG2*n and IgG3*b. A normal diluted serum pool was used and a panel of purified myeloma proteins as positive and negative controls. Determination of homozygosity and heterozygosity for the IgG2*n allotype was done with a double immuno diffusion assay with the monoclonal reagents anti IgG2*n clone SH21 and anti HP 6014 (Sigma, St. Louis, MO, USA) [11] . The control test for IgG3*g, beside absence of IgG3*b, was also the presence of the concordant IgG1*a allotype. In heterozygous individuals the IgG3*g and IgG3*b amounts are about 50:50%, respectively, of the IgG3 amount [4] .
In addition the quantities of allelic IgG subclasses were calculated from knowledge of the gene frequencies in a large Caucasian population of more than 2000 serum samples, with given proportions of the GM allotypes within the IgG subclasses for IgG3*b/ IgG3*g, 0.51/0.22 g/l, 70/30, for IgG1*f/IgG1*a 4.76/2.04 g/l, 70/30 and for IgG2*n/IgG2*-n, 1.5/1.83 g/l, 45/55 [4] (Fig.1 ). By the ELISA tests the quantitative expressions of IGHG genes are available. Total IgG subclass levels were measured with the Mancini technique. The allelic IgG subclass levels of the IGHG diplotypes of healthy adults and developmental rate during childhood have been given (Mean +/-SD) as references [4, 9] . The method to study genes by serum protein copies is advantageous, as the protein quantities in serum also disclose the rate of gene activity.
The ELISA method is the simplest way to demonstrate IGHG (GM) genes, their frequencies and quantities of allelic IgG subclasses. Investigations by RFLP, DNA and SNPs have had limited success. At present, the commonly used genome-wide association studies (GWAS) and HapMAP project do not include testable GM immunoglobulin genes in their genotyping platforms. This underscores the necessity of a candidate gene approach to investigate the role played by the GM gene complex in immunobiology [7] [8] [9] . The frequency figures for IGHG2 variants in Caucasians from different research groups were for the American: IGHG2*n/*n 34.3%, *n/*-n 16.2%, *-n/*-n 49.5% [12] for the Finnish: *n/*n 35.4%, *n/*-n 18.3%, *-n/*-n 43.7% [11] and for the present Swedish:*n/*n 34%, *n/*-n 22%, *-n/*-n 44% [9].
Structural differences of alternative allelic IgG subclasses
The alternative GM allotypes of the heavy constant 3, 1 and 2 chains are unique entities. In homozygous individuals the alternative allotypes are absent. They have different minor amino acid sequences (Table 6 ). It is evident that serologically defined allotypes within the IgG3 subclass are very complex. But IgG3*b is in strong linkage disequilibrium with IgG1*f and IgG3*g with IgG1*a. No alternative allotypes have been defined for IgG4.
The normal serum pool of 2000 Caucacian healthy adults was investigated for structural differences by immunochemical methods. The alternative allotypic (allelic) IgG subclass variants were found to have different rates by serum electrophoresis (preparative electrophoresis) ( Fig.3A) and different pH related rates by DEAE and Protein A-Sepharose chromatography [5] . Allotypic IgG subclasses of the IGHG*bfn haplotype were located anodally and those of the opposite IGHG*ga-n haplotype were located cathodally. IgG2*-n could be separated from IgG2*n and IgG3*g from IgG3*b molecules.This confirmed the unique structures of alternative allelic IgG subclasses.
The commercial IVIG preparations contain all 6 studied allelic IgG subclass variants as found in the normal serum pool. Allotypic IgG subclass (GM) quantities differed in various IVIG products. 7 commercial IVIG preparation, mean of five batches, respectively, were investigated for allelic IgG subclasses compared to a normal serum pool (2000 sera).
( Fig. 3B ). The different proportions are probably the result from different manufacturing processes.
In treated patients with homozygous IGHG, the levels of added structurally foreign settings of allelic IgG subclasses could easily be registered and different trough levels and half-life times recorded. Foreign IgG2*n was found to have longer half-life time than IgG1*f and IgG1*a ( Fig. 3C ) [13] . The commercial IVIG preparation have been thoroughly investigated for specific antibodies but not for allelic IgG subclasses. By collecting sera from blood donors of the same IGHG diplotypes, there is a possibility to make IgG preparations containing restrictive selective IgG molecules, without fractionation procedures. The homozygous diplotypes IGHG*bfn/*bfn and the structurally quite different IGHG*ga-n/*ga-n are most suitable in comparison for different functions in disease.
Functional differences of alternative allelic IgG subclasses
The Fc part establishes the function of the immunoglobulin molecule. By comparing the 10 individual IGHG diplotypes (6 common) of healthy, functional differences were disclosed.
They were found with different levels of IgG subclasses. In a healthy population the homozygous IGHG*bf-n/*bf-n expresses the lowest IgG2 levels and IGHG*ga-n/*ga-n the lowest IgG3 levels [9] . These diplotypes dominate also in IgG2-and IgG3-deficiencies [14] , respectively, but then with significantly low levels compared to IGHG matched healthy. Both contain the homozygous IGHG2*-n/*-n genotype but with opposite IGHG3 and IGHG1 alleles. It was found that all allotypes within the haplotype (B cell) have influence on the expression of the separate IgG subclass levels [9] . In childhood the allotypic IgG subclasses demonstrate different developmental rates. IgG2*n levels are retarded compared to the opposite IgG2*-n. The retarded IgG2*n levels could be compared to the known retarded levels of IgA during childhood. The IgG2 allotypic levels continue to increase in adulthood while the IgG1 allotypic levels decrease. 
Infections associated with IGHG (Fc) (GM) genes
There is a genetic control of survival in epidemics. Descendants of 367 Dutch colonists (100 families) who emigrated to Surinam in 1847, survived epidemics of typhoid and yellow fever with a total morality of 60%. The survivals were tested for GM allotypes (compared to a healthy Dutch population) comprising 88% (69%) IGHG*bfn & IGHG*bf-n and significantly low numbers 11% (29%) of IGHG*ga-n also according to our normal references (P<0.001) [15, 4] .Therefore these data might indicate selection through genetic control of survival in these epidemics.Various bacterias, virus and allergens affect individuals with particular IGHG haplotypes (B cells) more often. In addition various haplotypes are possibly discriminated as carriers or non carriers of bacteria or viruses. This could be the selective force for the maintenance of various frequencies of IGHG haplotypes, some common others very rare. By the Mendelian inheritance of IgG molecules there is a possibility that not all family members are affected by infections at the same time.
IGHG (Fc)(GM) gene susceptibility/resistence to bacterial infections
Neonatal septicaemia caused by streptococcus B was common in infants of mothers with the IGHG*ga-n/*ga-n diplotype, being carriers of streptococcus B [16] . The IgG2*-n allotype was associated with increased susceptibility to Haemophilus influenzae infections compared to IgG2*n (P<0.05) [17, 18] . Caucasian children less than 18 months with the IgG2*-n allotype have 5.1-fold higher risk of severe Hib infections than had those with IgG2*n.
Discordant GM allotypes correlate with different amounts of specific antibodies. The homozygous IGHG*bf-n/*bf-n correlate with the lowest levels of specific antibodies against polysaccharide antigens of pneumococci and meningococci [17, 18] . In Moraxella catarrhalis infections there were low levels of IgG3 and low levels of M protein specific antibodies in homozygous IGHG*ga-n/*ga-n [19, 20] . Chronic bronchitis is the most common diagnosis in IgG3D patients in whom the IGHG*ga-n/*ga-n diplotype is found in 70%.
Viral discrimination of IGHG (Fc)(GM) genes
Herpes simples type 1 has evolved strategies for decreasing the efficacy of the host immune response and interfering with viral clearance. Several studies have shown that HSV-1encoded FcR binds anti-HSV-1 antibodies by bipolar bridging: the Fab part of the antibody molecule binds to its antigenic target on the virus, whereas the Fc part of the antibody binds to the FcR-like binding site on the viral protein, thus offering survival advantage to the virus by sterically hindering the access of FcR-expressing effector cells eg. NK cells to HSV-1 infected cells. The HSV-1 encoded FcR discriminates between IgG1 molecules. The FcR binds IgG1*a more strongly than IgG1*f. This increased affinity to IgG1*a implies that subjects possessing IGHG1*a genes are more likely to have their Fc domains scavenged resulting in decreased immunocompetence to eliminate the virus and they would consequently be at higher risk of developing HSV-1-induced /spurred diseases [21] [22] [23] .
The FcR-like hepatitis C virus core protein has been found to bind differently to IgG of discordant GM (Fc) allotypes. IGHG genes are associated with the outcome of hepatitis C virus infection, GM modulate the viral strategy trough the different binding of the core protein. The absorbance value for binding HCV core protein is higher for IgG1*f than for IgG1*a (P=0.003) [24, 25] .
The Fc segment for human cytomegalovirus (HCMV) modulate the viral strategy through differential binding to the viral FcR. HCMV has evolved a large repertoire of strategies for evading immunosurvailance avoiding the effector consequencies of antibody binding ADCC, complement-dependent neutralization and phagocytosis. HCMV TRL11/IRL11 encoded FcR has increased binding to IGHG1*f compared to IGHG1*a, P=0.0005, with potential implications for genetic etiology of HCMV associated diseases [26] .
The host control of human immunodeficiency virus (HIV) replication has been found related to both FcR genes and Fc genes. In 73 Caucasian Americans who had spontaneously controlled HIV replication those with the FcRIIa allele combined with the IGHG3*b allele were found more often than those combined with IGHG3*g (OR=7.47) and those with the FcRIIIa allele combined with the IGHG3*b allele were found more often than those combined with IGHG3*g (OR=3.26) [27] .
Infants with the most severe infections of respiratory syncytial virus are predominantly found with the IGHG*bf-n/*bf-n diplotype, which also is found in non atopic asthma phenotypes [28] . and Streptococcus A, compared to IGHG2* -n/* -n with low numbers [17, 18, 29] .
Effects of immunotherapy in various
Heterozygotes IGHG2*n/*-n expressed intermediate responses disclosing a IGHG2*n gene dependency. After Hib polysaccharide vaccine the IgG1 responses were not significantly different in adults who were homozygous for IGHG2*n/*n and those who were homozygous IGHG2*-n/*-n. Similar results were found for children. The above results were obtained after vaccination of adults with unconjugated polysaccharide vaccines [12] . IgG3D patients with 70% IGHG*ga-n/*ga-n diplotypes demonstrated low prevaccination levels compared to controls but they responded well on a protein conjugated Hib vaccine [30] . The conjugate ACT-Hib vaccine overcomes the IgG3D state and the genetic predisposition for lower responsiveness [30] . The conventional Haemophilus polysaccharide is thought to be the thymic-independent type of immunogen, whereas the protein-conjugated vaccine is thymic dependent. Thymic dependent antigens are independent of regulation by genes associated with the IGHG2 locus. Thymic independent and thymic dependent antigens attack IGHG genes differently resulting in various amounts of specific antibodies. The insufficient or side effects of some vaccines may be due to the GM variation in the recipients.
Passive immunotherapy (IVIG, Therapeutic recombinant monoclonal antibodies)
The commercial IVIG preparations have been thoroughly investigated for numbers of specific antibodies, but not for amounts of allelic IgG subclasses. The commercial IVIG preparations contain all the allelic IgG subclasses but in slightly different proportions. (Fig. 3B ) Patients with immuno deficiencies and patients with autoimmune disorders often with homozygous IGHG genes and restricted IgG, are supported with foreign qualities of allelic IgG subclasses.
The foreign variants can be recorded directly and their half-life times assessed. In Common variable immunodeficiency (CVID) with homozygous IGHG*bf-n/*bf-n, the added foreign levels of IgG3*g, IgG1*a and IgG2*n could be followed (Fig. 3C) [13] . The survival of IgG2*n was prolonged compared to both IgG1*f and IgG1*a allotypic subclasses, in all four patients tested, but must be investigated further. In IVIG treatment, there is an advantage to know the IGHG genotype of the recipient, to calculate trough levels and survival times (Fig.   3C ).
There is an expanding usage of recombinant monoclonal antibodies as therapeutics.
Almost all of these are based on the whole IgG isotype format which employ the human constant region sequences, but vary in the origin of the variable regions between mouse, humanized mouse and fully human sequences. Polymorphisms (allotypes) within the IgG isotype originally demonstrated that allotypic variants can be immunogenic and provoke antibody responses as a result of allo-immunization. Allotype differences can contribute to or potentiate immunogenicity. Humanized antibodies may neutralize, enhance clearance or precipitate severe adverse reactions, in treatment of different diseases, and depends on the genetic constitution of the recipient. In patients with anti-therapeutic antibodies there is a possibility to trace the foreign allotypic IgG1 subclasses. Administration to patients homozygous for the alternative allotypes presents added potential for immunogenicity [31] .
The importance of "matched allotypes" could be speculated upon in passive immunotherapy.
Antibody-dependent cell-mediated cytotoxicity (ADCC) which links the innate and the adaptive arms of immunity, is a leading mechanism underlying the clinical efficiency of therapeutic antibodies such as trastuzumab and cetuximab. ADCC is triggered upon ligation of Fc receptor to the Fc region of the IgG molecules. There are differential inhibition of trastuzumab and cetuximab induced cytotoxicity of tumour antigens (human epidermal growth factor receptor antigens) of cancer cells by alternative IGHG1 genes IGHG1*f and IGHG1*a. Mechanism of resistence of cetuximab therapy is registered in colorectal cancer [32] . In passive immunotherapy with humanized (IgG1) mouse monoclonals, the foreign allelic IgG subclasses could be traced and half-life times registrated. .
IGHG gene frequencies in diseases and phenotypes of diseases
Immunodeficiency
IgG has a central role in primary immunodeficiency disorders (PID). Low serum IgG levels or hypogammaglobulinemia and low levels of IgG subclasses/or specific antibodies are correlated to diminished defence against pathogens in primary immunodeficiency disorders (PID). The expression of heavy constant 3-, 1and 2chain gene variants decide the qualities of the IgG3, IgG1 and IgG2 molecules. The fixed IGHG genes within the haplotypes (B cells) define also the quantities of allelic IgG subclasses molecules, registered in healthy (Table 5 ). In IgG2 deficiency there is a dominance of homozygous IGHG*bf-n/*bf-n and B2/B2 cells (IgG3*b, IgG1*f and IgG2*-n molecules) and absence of IgG3*g, IgG1*a and IgG2*n molecules. In the same way in IgG3deficiency, there is a dominance of homozygous IGHG*ga-n/*ga-n and B4/B4 cells (IgG3*g, IgG1*a and IgG2*-n) and absence of IgG3*b, IgG1*f and IgG2*n [14] . PID are found in family members however without known regulatory mechanisms, but often with IGHG genes in common.
In 235 children and adults with various PIDs, the IGHG2*-n/*-n (IgG2*-n) dominated [33] (Fig.4A) . The homozygous IGHG*bf-n/*bf-n diplotype (B2/B2 cells) dominated in IgG2D (P<0.001), in CVID (P<0.001), in IgAD (P=0.028) and in AT (P=0.042). The homozygous IGHG(*ga-n/*ga-n) diplotype (B4/B4 cells) dominated in IgG3D (P<0.001), in IgAD (P<0.001) and in WAS (P=0.002). IgG2D and CVID are both associated with the same homozygous IGHG*bf-n/*bf-n diplotype (B2/B2 cells) [33] . Both low levels and restricted qualities of IgG antibodies (Fc domains) expressed from different B cells have influence on pathogenesis. The IGHG*bfn/*bfn diplotypes (B1/B1 cells) with IgG2*n were found infrequently and seem to be protective. Primary monogenic defects as ataxia telangiectasia and Wiscott Aldrich syndrome due to single gene mutations, were also found with a dominance of the homozygous IGHG2*-n/*-n. The nature and extent of interactions between rare and common gene variants is currently unknown, but common variants may act as "modifier" genes that affect the clinical penetrance of rare variants analogous to the genetic model as described in monogenic conditions as WAS and AT. Particular IGHG genes may be risk factors by themselves, but combined with other factors they may add to developing disease. In these PID the IGHG*bf-n haplotype with the B *bf-n , B2 cells and the IGHG*ga-n haplotype with the B *ga-n , B4 cells dominated (Fig. 4A, 4B ). Investigation of frequencies of IGHG genes and quantities of allelic IgG subclasses, is a better way to describe antibody deficiencies than assessment of IgG subclasses alone.
Allergy
Asthma, eczema and hayfever are all manifestations of the atopic state, strongly familial on a multifactorial genetic basis. The genetic codes for immunoglobulin heavy constant chains for both IgE and IgG are found on chromosome 14q32.3. In childhood asthma the IgE-mediated allergy is associated with the IGHG*bfn haplotype. The highest IgE levels and highest numbers of positive skin prick tests are associated with homozygous IGHG*bfn/*bfn, B1/B1 cells. This is found in patients with clinical allergy and increased IgE levels, a family history of allergy and in technicians exposed to laboratory animals developing laboratory animal allergy [34] [35] [36] . The alternative IGHG haplotypes are linked to different pathways of immune regulation in patients with asthma. The IGHG*bfn haplotype from B1 cells is more prone to respond to allergens than other haplotypes and B cells. Severe IgE mediated allergy and asthma in children is associated with the homozygous IGHG*bfn/*bfn diplotype. IgE sensitisation is dependent on the IGHG2*n gene dose [36] . There is an increased frequency of the allelic IGHG2*n in patients with increased IgE>600kU/l and IgE>1000 kU/l, 76% and 88% respectively, but also in patients with increased IgG4 >1g/l , 94% compared to 46% in healthy ( Fig. 4C, 4D ). Children with bronchial asthma but with IgE levels < 10 kU/l are instead associated with the opposite IGHG*ga-n/*ga-n diplotype, infection proneness and IgG subclass deficiencies [34] . Children with bronchial asthma were mapped for the 6 most common IGHG diplotypes and investigated for phenotypes. The IGHG*bfn/*bfn diplotype was linked to the atopic phenotype and the opposite IGHG*ga-n/*ga-n was linked to the infectious proneness phenotype [36] . IGHG genes are involved in the IgE sensitization process. Childhood asthma patients with increased IgE have increased IgG2*n levels compared to IGHG gene-age-matched healthy children. Infants with the most severe infections of respiratory syncytial virus are predominantly found with the IGHG*bf-n/*bf-n diplotype, also found in non atopic phenotypes [28] . The most severe prognosis of patients with middle age asthma is found both in IGHG2*n/*n, the atopic phenotype, and the IGHG*-n/*-n the infectious prone phenotype [37] .
Autoimmunity
Homozygous IGHG diplotypes are associated with different prognoses in autoimmune disorders as in severe JCA with dominating IGHG*ga-n/*ga-n [38] . The best prognosis without severe infections in C2 deficiency (SLE) is found in patients with IGHG*bfn/*bfn [39] . Patients with increased IgG4 levels > 1g/l were occasionally found with the IGHG*bfn/*bfn diplotype, with the IgG2*n molecule in 94% compared to 46% in healthy (Fig.4C) . Patients with autoimmune disorders as well as immunodeficiencies express homozygous diplotypes with restricted IgG and the good effect by IVIG therapy is probably the support of foreign IgG molecules.
Malignancy
Different amounts of protecting antibodies have been observed in breast cancer associated with discordant GM allotypes [40] . Specific antibodies to mucin 1 (MUC 1) the membranebound glycoprotein that is overexpressed in adenocarcinomas are associated with good prognosis in patients with breast cancer. Anti-MUC1 IgG antibody levels in subjects who were carriers of the genetic variant IGHG2*n were significantly higher, compared to those who were non carriers with IGHG2*-n (P=0.003). These results could potentially devide the population into high and low responders to MUC 1, which has important implications for MUC 1-based immunotherapeutic interventions in breast cancer. It means that the specific antibody production were influenced by the IGHG2*n chain genes from the IGHG*bfn haplotype or B1 cells.
There is a strong rational for the involvement of GM genes in the prognosis of lung cancer by their possible involvement in antibody-dependent cell-mediated cytotoxicity (ADCC) a potent host immunosurveillance mechanism against tumors. IgG antibodymediated ADCC is triggered upon ligation of FcR to the Fc of IgG molecules to cause the destruction of lung cancer cells. Simultaneous genotyping of GM and Fc could significantly improve our ability to predict a patient´s prognosis of non-small cell lung cancer.
Homozygosity of IGHG*ga-n/*ga-n (B4/B4 cells) was dominating in lung cancer (P= 0.0009) [41] .
Conclusions
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